This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by McQuillen, P. S. Search for Related Content PubMed PubMed Citation Articles by McQuillen, P. S. Related Collections Pediatric and congenital heart disease, including cardiovascular surgery Computerized tomography and Magnetic Resonance Imaging

(Circulation. 2009;119:660-662.)
© 2009 American Heart Association, Inc.

Editorial

Magnetic Resonance Imaging in Congenital Heart Disease

What to Do With What We See and Don't See?

Patrick S. McQuillen, MD

From the Department of Pediatrics, University of California San Francisco, San Francisco.

Correspondence to Patrick S. McQuillen, MD, 513 Parnassus Ave, Rm HSE1421, UCSF Medical Center, San Francisco, CA 94143-0106. E-mail patrick.mcquillen@ucsf.edu

Key Words: Editorials • brain injuries • magnetic resonance imaging • stroke • transposition of great vessels

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Magnetic resonance imaging (MRI) is increasingly being applied to critically ill newborns with congenital heart disease (CHD) with the hope of understanding mechanisms accounting for adverse neurodevelopmental outcome. This powerful technique has opened an unprecedented window into normal development and pathogenesis during fetal life and surrounding surgery. Much as the technological advances of cardiopulmonary bypass, cardiac intensive care, and transcatheter and surgical techniques have translated into improved survival for neonates with complex congenital heart lesions, MRI promises to elucidate mechanisms and measure outcomes in a way that will inform treatment and establish neurointensive care to lessen neurologic morbidity. Many agree that improving neurodevelopmental outcome in CHD is the preeminent challenge to the field.¹ MRI studies in CHD have made the important and surprising observations that (1) brain injury is present before surgery,² (2) injury is most commonly focal affecting the white matter,³ and (3) brain development is delayed in term infants with CHD.⁴ Despite its promise as a sensitive early outcome variable that could be used to structure interventional studies with novel trial design,⁵ success to date has largely been descriptive, identifying clinical risk factors in limited case series. A particular challenge applying these findings to clinical practice is that the incidence of injury and associated risk factors are often unique to each form of CHD.⁶ For this reason, the approach has not substantially altered clinical care to date. However, several themes have emerged from multiple studies, providing confidence that the identified risk factors are valid and potent. These include . . . [Full Text of this Article]